Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 30 Jan 2026. The item focuses on Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147). Review the original article for the full source wording and details.